
Transition Therapeutics Inc. — Investor Relations & Filings
Transition Therapeutics is a biopharmaceutical company dedicated to the research and development of novel therapeutic agents for disease indications with large global markets. The company focuses on developing small molecule therapeutics primarily targeting CNS (Central Nervous System) and metabolic diseases, including treatments for Alzheimer's disease and diabetes. Its pipeline includes a lead drug candidate that has completed Phase II clinical trials.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Notice (amended).pdf | 2016-10-11 | English | |
| Notice.pdf | 2016-09-15 | English | |
| Material change report - English.pdf | 2016-09-09 | English | |
| News release - English.pdf | 2016-08-26 | English | |
| Report of voting results.pdf | 2016-08-26 | English | |
| Form of proxy - English.pdf | 2016-08-04 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2016
15 filings
| |||||
| 47109549 | Notice (amended).pdf | 2016-10-11 | English | ||
| 47109550 | Notice.pdf | 2016-09-15 | English | ||
| 47109551 | Material change report - English.pdf | 2016-09-09 | English | ||
| 47109556 | News release - English.pdf | 2016-08-26 | English | ||
| 47109557 | Report of voting results.pdf | 2016-08-26 | English | ||
| 47109558 | Form of proxy - English.pdf | 2016-08-04 | English | ||
| 47109597 | Other.pdf | 2016-08-04 | English | ||
| 47109617 | Notice of the meeting and record date - English.pdf | 2016-07-13 | English | ||
| 47109618 | Material change report - English.pdf | 2016-07-06 | English | ||
| 47109619 | Other.pdf | 2016-07-06 | English | ||
| 47109620 | News release - English.pdf | 2016-06-30 | English | ||
| 47109621 | News release - English.pdf | 2016-06-03 | English | ||
| 47109626 | News release - English.pdf | 2016-05-11 | English | ||
| 47109642 | Interim MD&A - English.pdf | 2016-05-11 | English | ||
| 47109643 | Other.pdf | 2016-05-11 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Viridian Therapeutics, Inc.\DE
Develops antibody-based therapies for serious and rare auto…
|
VRDN | US | Professional, scientific and te… |
|
VITRAFY LIFE SCIENCES LIMITED
Develops advanced cryopreservation and cold chain solutions…
|
VFY | AU | Professional, scientific and te… |
|
Viva Biotech Holdings
Integrated drug discovery, development, and manufacturing s…
|
1873 | KY | Professional, scientific and te… |
|
Viventia Biotech Inc.
Research and development of innovative, targeted oncology t…
|
— | CA | Professional, scientific and te… |
|
Vivo Bio tech Ltd.
Preclinical CRO providing drug discovery services and SPF l…
|
511509 | IN | Professional, scientific and te… |
|
VivoSim Labs, INC.
Develops 3D bioprinted human tissues for non-animal drug to…
|
VIVS | US | Professional, scientific and te… |
|
VOLITIONRX LTD
Epigenetics company developing blood tests for early diagno…
|
VNRX | US | Professional, scientific and te… |
|
Vor Biopharma Inc.
A clinical-stage biotech developing therapies that target t…
|
VOR | US | Professional, scientific and te… |
|
WDB coco CO.,LTD.
A CRO providing support services to the pharmaceutical and …
|
7079 | JP | Professional, scientific and te… |
|
Whitehawk Therapeutics, Inc.
A preclinical oncology company developing advanced antibody…
|
WHWK | US | Professional, scientific and te… |
Transition Therapeutics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/45117/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=45117 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=45117 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=45117 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 45117}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Transition Therapeutics Inc. (id: 45117)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.